- Home
- MGM vs EXEL Comparison
MGM vs EXEL Comparison
Compare MGM & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGM
- EXEL
- Stock Information
- Founded
- MGM 1986
- EXEL 1994
- Country
- MGM United States
- EXEL United States
- Employees
- MGM N/A
- EXEL N/A
- Industry
- MGM Hotels/Resorts
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MGM Consumer Discretionary
- EXEL Health Care
- Exchange
- MGM Nasdaq
- EXEL Nasdaq
- Market Cap
- MGM 9.9B
- EXEL 9.7B
- IPO Year
- MGM N/A
- EXEL 2000
- Fundamental
- Price
- MGM $32.83
- EXEL $36.20
- Analyst Decision
- MGM Strong Buy
- EXEL Buy
- Analyst Count
- MGM 15
- EXEL 17
- Target Price
- MGM $52.27
- EXEL $35.50
- AVG Volume (30 Days)
- MGM 4.4M
- EXEL 2.5M
- Earning Date
- MGM 02-12-2025
- EXEL 02-04-2025
- Dividend Yield
- MGM N/A
- EXEL N/A
- EPS Growth
- MGM N/A
- EXEL 441.02
- EPS
- MGM 2.82
- EXEL 1.55
- Revenue
- MGM $17,221,656,000.00
- EXEL $2,081,598,000.00
- Revenue This Year
- MGM $7.73
- EXEL $20.53
- Revenue Next Year
- MGM $0.14
- EXEL $0.95
- P/E Ratio
- MGM $11.67
- EXEL $23.39
- Revenue Growth
- MGM 12.31
- EXEL 17.31
- 52 Week Low
- MGM $31.61
- EXEL $20.02
- 52 Week High
- MGM $48.25
- EXEL $37.59
- Technical
- Relative Strength Index (RSI)
- MGM 37.71
- EXEL 58.54
- Support Level
- MGM $31.61
- EXEL $33.05
- Resistance Level
- MGM $34.05
- EXEL $37.59
- Average True Range (ATR)
- MGM 0.87
- EXEL 0.99
- MACD
- MGM 0.04
- EXEL 0.28
- Stochastic Oscillator
- MGM 34.56
- EXEL 69.38
About MGM MGM Resorts International
MGM Resorts is the largest resort operator on the Las Vegas Strip with 35,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Park MGM, Luxor, New York-New York, and Bellagio. The Strip contributed approximately 62% of total EBITDAR in 2023. MGM also owns US regional assets, which represented a low 20s share of 2023 EBITDAR (MGM's Macao EBITDAR was 17% of the total in 2023). MGM's US sports and i-gaming operations are currently a high-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM China casinos with a new property that opened on the Cotai Strip in early 2018. We estimate MGM will open a resort in Japan in 2030.
About EXEL Exelixis Inc.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.